\u79d1\u7814\u88fd\u85ac<\/a>\u2019IBD\u306e\u65b0\u305f\u306a\u6cbb\u7642\u9078\u629e\u80a2\u306e\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3001\u30a2\u30b8\u30a2\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u7684\u80fd\u529b\u3092\u6709\u3059\u308b\u300c\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u300d\u3092\u8a2d\u7acb\u3057\u307e\u3057\u305f\u3002.<\/p>","protected":false},"excerpt":{"rendered":"\u30cc\u30de\u30d6\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3068\u79d1\u7814\u88fd\u85ac\u306f\u3001\u708e\u75c7\u6027\u8178\u75be\u60a3\u306e\u521d\u306e\u6cbb\u7642\u85ac\u3068\u306a\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u65b0\u898f\u6297\u4f53NM81\u306e\u958b\u767a\u3067\u63d0\u643a\u3057\u307e\u3057\u305f\u3002\u79d1\u7814\u88fd\u85ac\u306f\u30012024\u5e7411\u6708\u304b\u3089\u306e\u7814\u7a76\u63d0\u643a\u306b\u7d9a\u304d\u3001\u30a2\u30b8\u30a2\u306e\u4e00\u90e8\u306e\u5730\u57df\u306b\u304a\u3051\u308bNM81\u306e\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002\u672c\u5951\u7d04\u306b\u3088\u308a\u3001Numab\u3068\u79d1\u7814\u88fd\u85ac\u306f\u5171\u540c\u3067NM81\u306e\u81e8\u5e8a\u958b\u767a\u3092\u9032\u3081\u3066\u3044\u304d\u307e\u3059\u3002Kaken\u793e\u306f\u3001\u524d\u81e8\u5e8a\u304a\u3088\u3073\u81e8\u5e8a\u958b\u767a\u306e\u4e21\u65b9\u306b\u8cc7\u91d1\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u672c\u5951\u7d04\u306b\u306f\u958b\u767a\u306b\u95a2\u3059\u308b\u8ca1\u52d9\u6761\u4ef6\u3082\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5171\u540c\u7814\u7a76\u304b\u3089\u751f\u307e\u308c\u305f\u88fd\u54c1\u304c\u6210\u529f\u3057\u305f\u5834\u5408\u3001Kaken\u793e\u306fNM81\u3092\u9032\u3081\u308b\u305f\u3081\u306e\u7814\u7a76\u958b\u767a\u6295\u8cc7\u3092\u53cd\u6620\u3057\u305f\u652f\u6255\u3044\u3092Numab\u793e\u304b\u3089\u53d7\u3051\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044NEXT Oncology\u793e\u304c\u95a2\u897f\u533b\u79d1\u5927\u5b66\u3068\u63d0\u643a \u3053\u306e\u63d0\u643a [...]...<\/p>","protected":false},"author":7,"featured_media":23979,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[150,2550,9204,9205,9206],"ppma_author":[572],"class_list":["post-23978","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-biotech","category-health-tech","category-japan","category-news","category-regional","tag-biotech","tag-clinical-development","tag-inflammatory-bowel-disease","tag-kaken-pharmaceutical","tag-numab-therapeutics"],"yoast_head":"\n
Numab & Kaken Team Up on NM81 for IBD Treatment<\/title>\n<meta name=\"description\" content=\"Numab and Kaken sign a strategic agreement to co-develop NM81, a novel multispecific antibody aimed at treating inflammatory bowel disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Numab & Kaken Team Up on NM81 for IBD Treatment\" \/>\n<meta property=\"og:description\" content=\"Numab and Kaken sign a strategic agreement to co-develop NM81, a novel multispecific antibody aimed at treating inflammatory bowel disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-14T12:16:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/Numab-Therapeutics-and-Kaken-Pharmaceutical-Announce-Licensing-and-Co-development-Agreement-for-Multispecific-Antibody-NM81-in-Inflammatory-Bowel-Disease-IBD.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30cc\u30de\u30d6\u3068\u79d1\u7814\u88fd\u85ac\u3001IBD\u6cbb\u7642\u85acNM81\u3067\u63d0\u643a","description":"\u30cc\u30de\u30d6\u3068\u79d1\u7814\u88fd\u85ac\u3001\u708e\u75c7\u6027\u8178\u75be\u60a3\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f\u591a\u7279\u7570\u6027\u6297\u4f53NM81\u306e\u5171\u540c\u958b\u767a\u306b\u95a2\u3059\u308b\u6226\u7565\u7684\u5951\u7d04\u3092\u7de0\u7d50.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/","og_locale":"ja_JP","og_type":"article","og_title":"Numab & Kaken Team Up on NM81 for IBD Treatment","og_description":"Numab and Kaken sign a strategic agreement to co-develop NM81, a novel multispecific antibody aimed at treating inflammatory bowel disease.","og_url":"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/","og_site_name":"itbusinesstoday","article_published_time":"2025-11-14T12:16:29+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/Numab-Therapeutics-and-Kaken-Pharmaceutical-Announce-Licensing-and-Co-development-Agreement-for-Multispecific-Antibody-NM81-in-Inflammatory-Bowel-Disease-IBD.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#article","isPartOf":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/person\/65e0b9dff93040ce4cd1ec0fb09d4cb3"},"headline":"Numab and Kaken Partner to Develop NM81 for IBD","datePublished":"2025-11-14T12:16:29+00:00","mainEntityOfPage":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/"},"wordCount":151,"publisher":{"@id":"https:\/\/demo.itbusinesstoday.com\/#organization"},"image":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#primaryimage"},"thumbnailUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/Numab-Therapeutics-and-Kaken-Pharmaceutical-Announce-Licensing-and-Co-development-Agreement-for-Multispecific-Antibody-NM81-in-Inflammatory-Bowel-Disease-IBD.webp","keywords":["Biotech","Clinical development","inflammatory bowel disease","Kaken Pharmaceutical","Numab Therapeutics"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/","url":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/","name":"\u30cc\u30de\u30d6\u3068\u79d1\u7814\u88fd\u85ac\u3001IBD\u6cbb\u7642\u85acNM81\u3067\u63d0\u643a","isPartOf":{"@id":"https:\/\/demo.itbusinesstoday.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#primaryimage"},"image":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#primaryimage"},"thumbnailUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/Numab-Therapeutics-and-Kaken-Pharmaceutical-Announce-Licensing-and-Co-development-Agreement-for-Multispecific-Antibody-NM81-in-Inflammatory-Bowel-Disease-IBD.webp","datePublished":"2025-11-14T12:16:29+00:00","description":"\u30cc\u30de\u30d6\u3068\u79d1\u7814\u88fd\u85ac\u3001\u708e\u75c7\u6027\u8178\u75be\u60a3\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f\u591a\u7279\u7570\u6027\u6297\u4f53NM81\u306e\u5171\u540c\u958b\u767a\u306b\u95a2\u3059\u308b\u6226\u7565\u7684\u5951\u7d04\u3092\u7de0\u7d50.","breadcrumb":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#primaryimage","url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/Numab-Therapeutics-and-Kaken-Pharmaceutical-Announce-Licensing-and-Co-development-Agreement-for-Multispecific-Antibody-NM81-in-Inflammatory-Bowel-Disease-IBD.webp","contentUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/11\/Numab-Therapeutics-and-Kaken-Pharmaceutical-Announce-Licensing-and-Co-development-Agreement-for-Multispecific-Antibody-NM81-in-Inflammatory-Bowel-Disease-IBD.webp","width":1200,"height":800,"caption":"Numab Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/numab-and-kaken-partner-to-develop-nm81-for-ibd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/demo.itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Numab and Kaken Partner to Develop NM81 for IBD"}]},{"@type":"WebSite","@id":"https:\/\/demo.itbusinesstoday.com\/#website","url":"https:\/\/demo.itbusinesstoday.com\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/demo.itbusinesstoday.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/demo.itbusinesstoday.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/demo.itbusinesstoday.com\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/demo.itbusinesstoday.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/logo\/image\/","url":"https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/person\/65e0b9dff93040ce4cd1ec0fb09d4cb3","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.pngb2476e2e1c1c4874e4c5d81a934febfb","url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/"],"url":"https:\/\/demo.itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/23978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=23978"}],"version-history":[{"count":3,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/23978\/revisions"}],"predecessor-version":[{"id":23991,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/23978\/revisions\/23991"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/23979"}],"wp:attachment":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=23978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=23978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=23978"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=23978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}